Status:
TERMINATED
Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
19-70 years
Phase:
PHASE4
Brief Summary
The goal of the study is to evaluate whether sitagliptin can affect postprandial lipoprotein metabolism in type 2 diabetic patients.
Eligibility Criteria
Inclusion
- type 2 diabetes
- dietary therapy
Exclusion
- lipid-lowering therapy
- anti-hyperglycemic drug therapy
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT00939939
Start Date
March 1 2010
End Date
May 1 2011
Last Update
June 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Dept. 2, Grosshadern, University Munich
Munich, Germany, 81377